Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

EN
Press Releases
Home  >  News  >  Press Releases
Building a Platform for Exchange and Sharing – The Second Annual Academic Conference of Chinese Society of Theoretical Innovation of Chinese Research Hospital Association held in Lianyungang
Release Date:2017/09/25
Font Size

In the golden autumn, at the foot of the Huaguo Mountain, the second annual academic conference of the Chinese Society of Theoretical Innovation of the Chinese Research Hospital Association was held in Lianyungang on September 22. More than 100 experts from the theoretical circle of research hospitals attended the conference to discuss the experience in building research hospitals and the latest academic progress of research hospitals.



Site of the second annual academic conference of the Chinese Society of Theoretical Innovation of the Chinese Research Hospital Association

The conference was hosted by the Chinese Research Hospital Association and co-hosted by Hansoh Pharma, etc., at which nearly 20 medical and health managers, experts and business representatives made keynote presentations.



At the conference, Ms. Fu Caiyun, Executive Vice President of Hansoh Pharma, and the representative of the Chinese Society of Theoretical Innovation signed a strategic cooperation agreement, according to which the two parties will establish collaboration in research on research hospital-related topics so as to help accelerate the Healthy China strategy.

Signing Ceremony of Strategic Cooperation Agreement

Hansoh's representative also made a keynote report on health poverty alleviation and briefed on Hansoh's efforts in this regard. The report pointed out that since its establishment, Hansoh Pharma has always adhered to the corporate mission of " create excellence in pharmaceuticals, enhance innovation in China ", and has steadily promoted the work of health poverty alleviation under the leadership of the competent authorities. Hansoh Pharma is committed to the research and development of innovative drugs, the supply of high-quality drugs and the dissemination of advanced medical knowledge, so as to allow Chinese people to enjoy international cutting-edge high-quality drugs and receive better medical and health services at affordable costs and help millions of patients restore their healthy lives. Hansoh has donated over RMB 100 million in total to fight natural disasters and major accidents and to fund free medical services and other poverty alleviation activities.

Hansoh Pharma also attaches great importance to cooperation with foundations in poverty alleviation and health personnel training. Through platform organizations such as the China Red Cross Society and China Pharmaceutical Innovation and Research Development Association, it has not only trained the population in remote and poor areas on the general knowledge of health and medicine, but also assisted in the training and engagement of medical and health talents in poor areas of central and western China, so as to improve the shortage of such talents and the low level of health awareness in such areas and guide local residents out of their predicament. In the field of mental health, the company has invested heavily to launch the "Love · Mental Health" special charity fund for mental health in China, aiming to promote mental health of the public and harmonious social development.

Despite all the efforts, we need to go one step further. In the future, Hansoh Pharma will continue to forge ahead, adhere to the innovation and go-global strategy, and make continuous efforts to improve the academic level of the industry and to promote the development of China's healthy poverty alleviation work and the improvement of human health.